Global Peptide Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
The Global Peptide Vaccine Market Size was estimated at USD 3842.05 million in 2023 and is projected to reach USD 4946.17 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Peptide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Vaccine market in any manner.
Global Peptide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Market Segmentation (by Type)
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Market Segmentation (by Application)
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
The Global Peptide Vaccine Market Size was estimated at USD 3842.05 million in 2023 and is projected to reach USD 4946.17 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Peptide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Vaccine market in any manner.
Global Peptide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Market Segmentation (by Type)
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Market Segmentation (by Application)
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Peptide Vaccine Market
- Overview of the regional outlook of the Peptide Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peptide Vaccine
1.2 Key Market Segments
1.2.1 Peptide Vaccine Segment by Type
1.2.2 Peptide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peptide Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Peptide Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Peptide Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peptide Vaccine Sales Sites, Area Served, Product Type
3.6 Peptide Vaccine Market Competitive Situation and Trends
3.6.1 Peptide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEPTIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Peptide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEPTIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Peptide Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Peptide Vaccine Price by Type (2019-2024)
7 PEPTIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Vaccine Market Sales by Application (2019-2024)
7.3 Global Peptide Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
8 PEPTIDE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Peptide Vaccine Sales by Region
8.1.1 Global Peptide Vaccine Sales by Region
8.1.2 Global Peptide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Anergis
9.1.1 Anergis Peptide Vaccine Basic Information
9.1.2 Anergis Peptide Vaccine Product Overview
9.1.3 Anergis Peptide Vaccine Product Market Performance
9.1.4 Anergis Business Overview
9.1.5 Anergis Peptide Vaccine SWOT Analysis
9.1.6 Anergis Recent Developments
9.2 Antigen Express
9.2.1 Antigen Express Peptide Vaccine Basic Information
9.2.2 Antigen Express Peptide Vaccine Product Overview
9.2.3 Antigen Express Peptide Vaccine Product Market Performance
9.2.4 Antigen Express Business Overview
9.2.5 Antigen Express Peptide Vaccine SWOT Analysis
9.2.6 Antigen Express Recent Developments
9.3 Apitope Technology
9.3.1 Apitope Technology Peptide Vaccine Basic Information
9.3.2 Apitope Technology Peptide Vaccine Product Overview
9.3.3 Apitope Technology Peptide Vaccine Product Market Performance
9.3.4 Apitope Technology Peptide Vaccine SWOT Analysis
9.3.5 Apitope Technology Business Overview
9.3.6 Apitope Technology Recent Developments
9.4 Artificial Cell Technologies
9.4.1 Artificial Cell Technologies Peptide Vaccine Basic Information
9.4.2 Artificial Cell Technologies Peptide Vaccine Product Overview
9.4.3 Artificial Cell Technologies Peptide Vaccine Product Market Performance
9.4.4 Artificial Cell Technologies Business Overview
9.4.5 Artificial Cell Technologies Recent Developments
9.5 Benovus Bio
9.5.1 Benovus Bio Peptide Vaccine Basic Information
9.5.2 Benovus Bio Peptide Vaccine Product Overview
9.5.3 Benovus Bio Peptide Vaccine Product Market Performance
9.5.4 Benovus Bio Business Overview
9.5.5 Benovus Bio Recent Developments
9.6 Celgene Corporation
9.6.1 Celgene Corporation Peptide Vaccine Basic Information
9.6.2 Celgene Corporation Peptide Vaccine Product Overview
9.6.3 Celgene Corporation Peptide Vaccine Product Market Performance
9.6.4 Celgene Corporation Business Overview
9.6.5 Celgene Corporation Recent Developments
9.7 Immatics biotechnologies
9.7.1 Immatics biotechnologies Peptide Vaccine Basic Information
9.7.2 Immatics biotechnologies Peptide Vaccine Product Overview
9.7.3 Immatics biotechnologies Peptide Vaccine Product Market Performance
9.7.4 Immatics biotechnologies Business Overview
9.7.5 Immatics biotechnologies Recent Developments
9.8 Merck
9.8.1 Merck Peptide Vaccine Basic Information
9.8.2 Merck Peptide Vaccine Product Overview
9.8.3 Merck Peptide Vaccine Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 ImmunoCellular Therapeutics
9.9.1 ImmunoCellular Therapeutics Peptide Vaccine Basic Information
9.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Overview
9.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product Market Performance
9.9.4 ImmunoCellular Therapeutics Business Overview
9.9.5 ImmunoCellular Therapeutics Recent Developments
9.10 ISA Pharmaceuticals
9.10.1 ISA Pharmaceuticals Peptide Vaccine Basic Information
9.10.2 ISA Pharmaceuticals Peptide Vaccine Product Overview
9.10.3 ISA Pharmaceuticals Peptide Vaccine Product Market Performance
9.10.4 ISA Pharmaceuticals Business Overview
9.10.5 ISA Pharmaceuticals Recent Developments
9.11 Lytix Biopharma
9.11.1 Lytix Biopharma Peptide Vaccine Basic Information
9.11.2 Lytix Biopharma Peptide Vaccine Product Overview
9.11.3 Lytix Biopharma Peptide Vaccine Product Market Performance
9.11.4 Lytix Biopharma Business Overview
9.11.5 Lytix Biopharma Recent Developments
9.12 Spotlight Innovation
9.12.1 Spotlight Innovation Peptide Vaccine Basic Information
9.12.2 Spotlight Innovation Peptide Vaccine Product Overview
9.12.3 Spotlight Innovation Peptide Vaccine Product Market Performance
9.12.4 Spotlight Innovation Business Overview
9.12.5 Spotlight Innovation Recent Developments
9.13 OncoTherapy Science
9.13.1 OncoTherapy Science Peptide Vaccine Basic Information
9.13.2 OncoTherapy Science Peptide Vaccine Product Overview
9.13.3 OncoTherapy Science Peptide Vaccine Product Market Performance
9.13.4 OncoTherapy Science Business Overview
9.13.5 OncoTherapy Science Recent Developments
9.14 Peptech
9.14.1 Peptech Peptide Vaccine Basic Information
9.14.2 Peptech Peptide Vaccine Product Overview
9.14.3 Peptech Peptide Vaccine Product Market Performance
9.14.4 Peptech Business Overview
9.14.5 Peptech Recent Developments
9.15 Pharmasyntez
9.15.1 Pharmasyntez Peptide Vaccine Basic Information
9.15.2 Pharmasyntez Peptide Vaccine Product Overview
9.15.3 Pharmasyntez Peptide Vaccine Product Market Performance
9.15.4 Pharmasyntez Business Overview
9.15.5 Pharmasyntez Recent Developments
9.16 Sumitomo Dainippon Pharma
9.16.1 Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
9.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
9.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product Market Performance
9.16.4 Sumitomo Dainippon Pharma Business Overview
9.16.5 Sumitomo Dainippon Pharma Recent Developments
9.17 TapImmune
9.17.1 TapImmune Peptide Vaccine Basic Information
9.17.2 TapImmune Peptide Vaccine Product Overview
9.17.3 TapImmune Peptide Vaccine Product Market Performance
9.17.4 TapImmune Business Overview
9.17.5 TapImmune Recent Developments
9.18 Targovax
9.18.1 Targovax Peptide Vaccine Basic Information
9.18.2 Targovax Peptide Vaccine Product Overview
9.18.3 Targovax Peptide Vaccine Product Market Performance
9.18.4 Targovax Business Overview
9.18.5 Targovax Recent Developments
10 PEPTIDE VACCINE MARKET FORECAST BY REGION
10.1 Global Peptide Vaccine Market Size Forecast
10.2 Global Peptide Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Peptide Vaccine Market Size Forecast by Region
10.2.4 South America Peptide Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peptide Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peptide Vaccine by Type (2025-2030)
11.1.2 Global Peptide Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peptide Vaccine by Type (2025-2030)
11.2 Global Peptide Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Peptide Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Peptide Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peptide Vaccine
1.2 Key Market Segments
1.2.1 Peptide Vaccine Segment by Type
1.2.2 Peptide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peptide Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Peptide Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Peptide Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peptide Vaccine Sales Sites, Area Served, Product Type
3.6 Peptide Vaccine Market Competitive Situation and Trends
3.6.1 Peptide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEPTIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Peptide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEPTIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Peptide Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Peptide Vaccine Price by Type (2019-2024)
7 PEPTIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Vaccine Market Sales by Application (2019-2024)
7.3 Global Peptide Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
8 PEPTIDE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Peptide Vaccine Sales by Region
8.1.1 Global Peptide Vaccine Sales by Region
8.1.2 Global Peptide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Anergis
9.1.1 Anergis Peptide Vaccine Basic Information
9.1.2 Anergis Peptide Vaccine Product Overview
9.1.3 Anergis Peptide Vaccine Product Market Performance
9.1.4 Anergis Business Overview
9.1.5 Anergis Peptide Vaccine SWOT Analysis
9.1.6 Anergis Recent Developments
9.2 Antigen Express
9.2.1 Antigen Express Peptide Vaccine Basic Information
9.2.2 Antigen Express Peptide Vaccine Product Overview
9.2.3 Antigen Express Peptide Vaccine Product Market Performance
9.2.4 Antigen Express Business Overview
9.2.5 Antigen Express Peptide Vaccine SWOT Analysis
9.2.6 Antigen Express Recent Developments
9.3 Apitope Technology
9.3.1 Apitope Technology Peptide Vaccine Basic Information
9.3.2 Apitope Technology Peptide Vaccine Product Overview
9.3.3 Apitope Technology Peptide Vaccine Product Market Performance
9.3.4 Apitope Technology Peptide Vaccine SWOT Analysis
9.3.5 Apitope Technology Business Overview
9.3.6 Apitope Technology Recent Developments
9.4 Artificial Cell Technologies
9.4.1 Artificial Cell Technologies Peptide Vaccine Basic Information
9.4.2 Artificial Cell Technologies Peptide Vaccine Product Overview
9.4.3 Artificial Cell Technologies Peptide Vaccine Product Market Performance
9.4.4 Artificial Cell Technologies Business Overview
9.4.5 Artificial Cell Technologies Recent Developments
9.5 Benovus Bio
9.5.1 Benovus Bio Peptide Vaccine Basic Information
9.5.2 Benovus Bio Peptide Vaccine Product Overview
9.5.3 Benovus Bio Peptide Vaccine Product Market Performance
9.5.4 Benovus Bio Business Overview
9.5.5 Benovus Bio Recent Developments
9.6 Celgene Corporation
9.6.1 Celgene Corporation Peptide Vaccine Basic Information
9.6.2 Celgene Corporation Peptide Vaccine Product Overview
9.6.3 Celgene Corporation Peptide Vaccine Product Market Performance
9.6.4 Celgene Corporation Business Overview
9.6.5 Celgene Corporation Recent Developments
9.7 Immatics biotechnologies
9.7.1 Immatics biotechnologies Peptide Vaccine Basic Information
9.7.2 Immatics biotechnologies Peptide Vaccine Product Overview
9.7.3 Immatics biotechnologies Peptide Vaccine Product Market Performance
9.7.4 Immatics biotechnologies Business Overview
9.7.5 Immatics biotechnologies Recent Developments
9.8 Merck
9.8.1 Merck Peptide Vaccine Basic Information
9.8.2 Merck Peptide Vaccine Product Overview
9.8.3 Merck Peptide Vaccine Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 ImmunoCellular Therapeutics
9.9.1 ImmunoCellular Therapeutics Peptide Vaccine Basic Information
9.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Overview
9.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product Market Performance
9.9.4 ImmunoCellular Therapeutics Business Overview
9.9.5 ImmunoCellular Therapeutics Recent Developments
9.10 ISA Pharmaceuticals
9.10.1 ISA Pharmaceuticals Peptide Vaccine Basic Information
9.10.2 ISA Pharmaceuticals Peptide Vaccine Product Overview
9.10.3 ISA Pharmaceuticals Peptide Vaccine Product Market Performance
9.10.4 ISA Pharmaceuticals Business Overview
9.10.5 ISA Pharmaceuticals Recent Developments
9.11 Lytix Biopharma
9.11.1 Lytix Biopharma Peptide Vaccine Basic Information
9.11.2 Lytix Biopharma Peptide Vaccine Product Overview
9.11.3 Lytix Biopharma Peptide Vaccine Product Market Performance
9.11.4 Lytix Biopharma Business Overview
9.11.5 Lytix Biopharma Recent Developments
9.12 Spotlight Innovation
9.12.1 Spotlight Innovation Peptide Vaccine Basic Information
9.12.2 Spotlight Innovation Peptide Vaccine Product Overview
9.12.3 Spotlight Innovation Peptide Vaccine Product Market Performance
9.12.4 Spotlight Innovation Business Overview
9.12.5 Spotlight Innovation Recent Developments
9.13 OncoTherapy Science
9.13.1 OncoTherapy Science Peptide Vaccine Basic Information
9.13.2 OncoTherapy Science Peptide Vaccine Product Overview
9.13.3 OncoTherapy Science Peptide Vaccine Product Market Performance
9.13.4 OncoTherapy Science Business Overview
9.13.5 OncoTherapy Science Recent Developments
9.14 Peptech
9.14.1 Peptech Peptide Vaccine Basic Information
9.14.2 Peptech Peptide Vaccine Product Overview
9.14.3 Peptech Peptide Vaccine Product Market Performance
9.14.4 Peptech Business Overview
9.14.5 Peptech Recent Developments
9.15 Pharmasyntez
9.15.1 Pharmasyntez Peptide Vaccine Basic Information
9.15.2 Pharmasyntez Peptide Vaccine Product Overview
9.15.3 Pharmasyntez Peptide Vaccine Product Market Performance
9.15.4 Pharmasyntez Business Overview
9.15.5 Pharmasyntez Recent Developments
9.16 Sumitomo Dainippon Pharma
9.16.1 Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
9.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
9.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product Market Performance
9.16.4 Sumitomo Dainippon Pharma Business Overview
9.16.5 Sumitomo Dainippon Pharma Recent Developments
9.17 TapImmune
9.17.1 TapImmune Peptide Vaccine Basic Information
9.17.2 TapImmune Peptide Vaccine Product Overview
9.17.3 TapImmune Peptide Vaccine Product Market Performance
9.17.4 TapImmune Business Overview
9.17.5 TapImmune Recent Developments
9.18 Targovax
9.18.1 Targovax Peptide Vaccine Basic Information
9.18.2 Targovax Peptide Vaccine Product Overview
9.18.3 Targovax Peptide Vaccine Product Market Performance
9.18.4 Targovax Business Overview
9.18.5 Targovax Recent Developments
10 PEPTIDE VACCINE MARKET FORECAST BY REGION
10.1 Global Peptide Vaccine Market Size Forecast
10.2 Global Peptide Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Peptide Vaccine Market Size Forecast by Region
10.2.4 South America Peptide Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peptide Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peptide Vaccine by Type (2025-2030)
11.1.2 Global Peptide Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peptide Vaccine by Type (2025-2030)
11.2 Global Peptide Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Peptide Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Peptide Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Peptide Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Peptide Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peptide Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peptide Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2022)
Table 10. Global Market Peptide Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peptide Vaccine Sales Sites and Area Served
Table 12. Manufacturers Peptide Vaccine Product Type
Table 13. Global Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Vaccine Market Challenges
Table 22. Global Peptide Vaccine Sales by Type (Kilotons)
Table 23. Global Peptide Vaccine Market Size by Type (M USD)
Table 24. Global Peptide Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Peptide Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Peptide Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Peptide Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Peptide Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Peptide Vaccine Sales (Kilotons) by Application
Table 30. Global Peptide Vaccine Market Size by Application
Table 31. Global Peptide Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Peptide Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Peptide Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Peptide Vaccine Market Share by Application (2019-2024)
Table 35. Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Peptide Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Anergis Peptide Vaccine Basic Information
Table 44. Anergis Peptide Vaccine Product Overview
Table 45. Anergis Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Anergis Business Overview
Table 47. Anergis Peptide Vaccine SWOT Analysis
Table 48. Anergis Recent Developments
Table 49. Antigen Express Peptide Vaccine Basic Information
Table 50. Antigen Express Peptide Vaccine Product Overview
Table 51. Antigen Express Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Antigen Express Business Overview
Table 53. Antigen Express Peptide Vaccine SWOT Analysis
Table 54. Antigen Express Recent Developments
Table 55. Apitope Technology Peptide Vaccine Basic Information
Table 56. Apitope Technology Peptide Vaccine Product Overview
Table 57. Apitope Technology Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Apitope Technology Peptide Vaccine SWOT Analysis
Table 59. Apitope Technology Business Overview
Table 60. Apitope Technology Recent Developments
Table 61. Artificial Cell Technologies Peptide Vaccine Basic Information
Table 62. Artificial Cell Technologies Peptide Vaccine Product Overview
Table 63. Artificial Cell Technologies Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Artificial Cell Technologies Business Overview
Table 65. Artificial Cell Technologies Recent Developments
Table 66. Benovus Bio Peptide Vaccine Basic Information
Table 67. Benovus Bio Peptide Vaccine Product Overview
Table 68. Benovus Bio Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Benovus Bio Business Overview
Table 70. Benovus Bio Recent Developments
Table 71. Celgene Corporation Peptide Vaccine Basic Information
Table 72. Celgene Corporation Peptide Vaccine Product Overview
Table 73. Celgene Corporation Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Recent Developments
Table 76. Immatics biotechnologies Peptide Vaccine Basic Information
Table 77. Immatics biotechnologies Peptide Vaccine Product Overview
Table 78. Immatics biotechnologies Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Immatics biotechnologies Business Overview
Table 80. Immatics biotechnologies Recent Developments
Table 81. Merck Peptide Vaccine Basic Information
Table 82. Merck Peptide Vaccine Product Overview
Table 83. Merck Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. ImmunoCellular Therapeutics Peptide Vaccine Basic Information
Table 87. ImmunoCellular Therapeutics Peptide Vaccine Product Overview
Table 88. ImmunoCellular Therapeutics Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ImmunoCellular Therapeutics Business Overview
Table 90. ImmunoCellular Therapeutics Recent Developments
Table 91. ISA Pharmaceuticals Peptide Vaccine Basic Information
Table 92. ISA Pharmaceuticals Peptide Vaccine Product Overview
Table 93. ISA Pharmaceuticals Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. ISA Pharmaceuticals Business Overview
Table 95. ISA Pharmaceuticals Recent Developments
Table 96. Lytix Biopharma Peptide Vaccine Basic Information
Table 97. Lytix Biopharma Peptide Vaccine Product Overview
Table 98. Lytix Biopharma Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Lytix Biopharma Business Overview
Table 100. Lytix Biopharma Recent Developments
Table 101. Spotlight Innovation Peptide Vaccine Basic Information
Table 102. Spotlight Innovation Peptide Vaccine Product Overview
Table 103. Spotlight Innovation Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Spotlight Innovation Business Overview
Table 105. Spotlight Innovation Recent Developments
Table 106. OncoTherapy Science Peptide Vaccine Basic Information
Table 107. OncoTherapy Science Peptide Vaccine Product Overview
Table 108. OncoTherapy Science Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. OncoTherapy Science Business Overview
Table 110. OncoTherapy Science Recent Developments
Table 111. Peptech Peptide Vaccine Basic Information
Table 112. Peptech Peptide Vaccine Product Overview
Table 113. Peptech Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Peptech Business Overview
Table 115. Peptech Recent Developments
Table 116. Pharmasyntez Peptide Vaccine Basic Information
Table 117. Pharmasyntez Peptide Vaccine Product Overview
Table 118. Pharmasyntez Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Pharmasyntez Business Overview
Table 120. Pharmasyntez Recent Developments
Table 121. Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
Table 122. Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
Table 123. Sumitomo Dainippon Pharma Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Sumitomo Dainippon Pharma Business Overview
Table 125. Sumitomo Dainippon Pharma Recent Developments
Table 126. TapImmune Peptide Vaccine Basic Information
Table 127. TapImmune Peptide Vaccine Product Overview
Table 128. TapImmune Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. TapImmune Business Overview
Table 130. TapImmune Recent Developments
Table 131. Targovax Peptide Vaccine Basic Information
Table 132. Targovax Peptide Vaccine Product Overview
Table 133. Targovax Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Targovax Business Overview
Table 135. Targovax Recent Developments
Table 136. Global Peptide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Peptide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Peptide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Peptide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Peptide Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Peptide Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Peptide Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Peptide Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Peptide Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Peptide Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Peptide Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Peptide Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peptide Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peptide Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2022)
Table 10. Global Market Peptide Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peptide Vaccine Sales Sites and Area Served
Table 12. Manufacturers Peptide Vaccine Product Type
Table 13. Global Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Vaccine Market Challenges
Table 22. Global Peptide Vaccine Sales by Type (Kilotons)
Table 23. Global Peptide Vaccine Market Size by Type (M USD)
Table 24. Global Peptide Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Peptide Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Peptide Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Peptide Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Peptide Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Peptide Vaccine Sales (Kilotons) by Application
Table 30. Global Peptide Vaccine Market Size by Application
Table 31. Global Peptide Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Peptide Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Peptide Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Peptide Vaccine Market Share by Application (2019-2024)
Table 35. Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Peptide Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Peptide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Peptide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Anergis Peptide Vaccine Basic Information
Table 44. Anergis Peptide Vaccine Product Overview
Table 45. Anergis Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Anergis Business Overview
Table 47. Anergis Peptide Vaccine SWOT Analysis
Table 48. Anergis Recent Developments
Table 49. Antigen Express Peptide Vaccine Basic Information
Table 50. Antigen Express Peptide Vaccine Product Overview
Table 51. Antigen Express Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Antigen Express Business Overview
Table 53. Antigen Express Peptide Vaccine SWOT Analysis
Table 54. Antigen Express Recent Developments
Table 55. Apitope Technology Peptide Vaccine Basic Information
Table 56. Apitope Technology Peptide Vaccine Product Overview
Table 57. Apitope Technology Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Apitope Technology Peptide Vaccine SWOT Analysis
Table 59. Apitope Technology Business Overview
Table 60. Apitope Technology Recent Developments
Table 61. Artificial Cell Technologies Peptide Vaccine Basic Information
Table 62. Artificial Cell Technologies Peptide Vaccine Product Overview
Table 63. Artificial Cell Technologies Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Artificial Cell Technologies Business Overview
Table 65. Artificial Cell Technologies Recent Developments
Table 66. Benovus Bio Peptide Vaccine Basic Information
Table 67. Benovus Bio Peptide Vaccine Product Overview
Table 68. Benovus Bio Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Benovus Bio Business Overview
Table 70. Benovus Bio Recent Developments
Table 71. Celgene Corporation Peptide Vaccine Basic Information
Table 72. Celgene Corporation Peptide Vaccine Product Overview
Table 73. Celgene Corporation Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Recent Developments
Table 76. Immatics biotechnologies Peptide Vaccine Basic Information
Table 77. Immatics biotechnologies Peptide Vaccine Product Overview
Table 78. Immatics biotechnologies Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Immatics biotechnologies Business Overview
Table 80. Immatics biotechnologies Recent Developments
Table 81. Merck Peptide Vaccine Basic Information
Table 82. Merck Peptide Vaccine Product Overview
Table 83. Merck Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. ImmunoCellular Therapeutics Peptide Vaccine Basic Information
Table 87. ImmunoCellular Therapeutics Peptide Vaccine Product Overview
Table 88. ImmunoCellular Therapeutics Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ImmunoCellular Therapeutics Business Overview
Table 90. ImmunoCellular Therapeutics Recent Developments
Table 91. ISA Pharmaceuticals Peptide Vaccine Basic Information
Table 92. ISA Pharmaceuticals Peptide Vaccine Product Overview
Table 93. ISA Pharmaceuticals Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. ISA Pharmaceuticals Business Overview
Table 95. ISA Pharmaceuticals Recent Developments
Table 96. Lytix Biopharma Peptide Vaccine Basic Information
Table 97. Lytix Biopharma Peptide Vaccine Product Overview
Table 98. Lytix Biopharma Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Lytix Biopharma Business Overview
Table 100. Lytix Biopharma Recent Developments
Table 101. Spotlight Innovation Peptide Vaccine Basic Information
Table 102. Spotlight Innovation Peptide Vaccine Product Overview
Table 103. Spotlight Innovation Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Spotlight Innovation Business Overview
Table 105. Spotlight Innovation Recent Developments
Table 106. OncoTherapy Science Peptide Vaccine Basic Information
Table 107. OncoTherapy Science Peptide Vaccine Product Overview
Table 108. OncoTherapy Science Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. OncoTherapy Science Business Overview
Table 110. OncoTherapy Science Recent Developments
Table 111. Peptech Peptide Vaccine Basic Information
Table 112. Peptech Peptide Vaccine Product Overview
Table 113. Peptech Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Peptech Business Overview
Table 115. Peptech Recent Developments
Table 116. Pharmasyntez Peptide Vaccine Basic Information
Table 117. Pharmasyntez Peptide Vaccine Product Overview
Table 118. Pharmasyntez Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Pharmasyntez Business Overview
Table 120. Pharmasyntez Recent Developments
Table 121. Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
Table 122. Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
Table 123. Sumitomo Dainippon Pharma Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Sumitomo Dainippon Pharma Business Overview
Table 125. Sumitomo Dainippon Pharma Recent Developments
Table 126. TapImmune Peptide Vaccine Basic Information
Table 127. TapImmune Peptide Vaccine Product Overview
Table 128. TapImmune Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. TapImmune Business Overview
Table 130. TapImmune Recent Developments
Table 131. Targovax Peptide Vaccine Basic Information
Table 132. Targovax Peptide Vaccine Product Overview
Table 133. Targovax Peptide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Targovax Business Overview
Table 135. Targovax Recent Developments
Table 136. Global Peptide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Peptide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Peptide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Peptide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Peptide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Peptide Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Peptide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Peptide Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Peptide Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Peptide Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Peptide Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Peptide Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peptide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Peptide Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Peptide Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Vaccine Market Size by Country (M USD)
Figure 11. Peptide Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Peptide Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide Vaccine Market Share by Type
Figure 18. Sales Market Share of Peptide Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Peptide Vaccine by Type in 2023
Figure 20. Market Size Share of Peptide Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Peptide Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Vaccine Market Share by Application
Figure 24. Global Peptide Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Peptide Vaccine Sales Market Share by Application in 2023
Figure 26. Global Peptide Vaccine Market Share by Application (2019-2024)
Figure 27. Global Peptide Vaccine Market Share by Application in 2023
Figure 28. Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peptide Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Peptide Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Peptide Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Peptide Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Peptide Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Peptide Vaccine Sales Market Share by Region in 2023
Figure 44. China Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Peptide Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Peptide Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Peptide Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Peptide Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peptide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peptide Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Peptide Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Peptide Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Peptide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Peptide Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Peptide Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Vaccine Market Size by Country (M USD)
Figure 11. Peptide Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Peptide Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide Vaccine Market Share by Type
Figure 18. Sales Market Share of Peptide Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Peptide Vaccine by Type in 2023
Figure 20. Market Size Share of Peptide Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Peptide Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Vaccine Market Share by Application
Figure 24. Global Peptide Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Peptide Vaccine Sales Market Share by Application in 2023
Figure 26. Global Peptide Vaccine Market Share by Application (2019-2024)
Figure 27. Global Peptide Vaccine Market Share by Application in 2023
Figure 28. Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peptide Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Peptide Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Peptide Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Peptide Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Peptide Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Peptide Vaccine Sales Market Share by Region in 2023
Figure 44. China Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Peptide Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Peptide Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Peptide Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Peptide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Peptide Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Peptide Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peptide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peptide Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Peptide Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Peptide Vaccine Market Share Forecast by Application (2025-2030)
